DOCSLIB.ORG

Drugcheck Cups +Alcohol Drug Test Catalog Dip & Reads

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Drugcheck Cups +Alcohol Drug Test Catalog Dip & Reads DRUGCHECK CUPS +ALCOHOL DRUG TEST CATALOG DIP & READS CLIA WAIVED CUPS BREATHALYZERS PIPETTE TESTS ALCO SCREEN NICOTINE TESTS DRUG TEST CUPS SALIVA DRUG TESTS COLLECTION SUPPLIES D-TAP The-Drug Test Awareness Program 601 Business Loop 70 W | Suite 214 D | Columbia | MO | 65203 Phone: 888.230.7424 | Email: [email protected] www.DrugTestAwareness.com 1 DRUGCHECKCONTACT CUPS US +ALCOHOL D-TAP The-Drug Test Awareness Program 601 Business Loop 70 W | Suite 214 D | Columbia | MO | 65203 Phone: 888.230.7424 | Email: [email protected] www.DrugTestAwareness.com If you have questions or wish to place an order, please contact us. We’re happy to help! 2 TABLE OF CONTENTS CLIA Waived 4 CLIA Waived T-Cups 23 Dip & Read Tests 5 CLIA Screen Cups 25 DrugCheck Dip & Read Tests 7 Integrated EZ Split Key Cup 26 Additional Dip & Read Tests 9 iCUP 27 Economy Five Panel Dip 11 Pipette Tests 29 12 Panel CLIA Waived Dip 12 Oralert and Iscreen 31 Specialty Dip and Reads 13 Oratect 32 Adulteration Test 15 Stat Swab 33 Nicotine Tests 16 Oral Cube 34 Alco Screen 17 Specimen Collection Cups 35 EtG Alcohol Test 18 Breathalyzers 36 DrugCheck Cups 19 Collection Supplies 38 T-Cups 21 DRUG ABBREVIATIONS AMP Amphetamines MOP Opiates300 BAR Barbiturate OPI Opiates2000 BUP Buprenorphine PCP Phencyclidine BZO Benzodiazepine PPX Propoxyphene COC Cocaine TCA Tricyclic Antidepressants mAMP Methamphetamines THC Marijuana MDMA Ecstasy MTD Methadone OXY Oxycodone K2 K2/Spice TRM Tramadol ALC Alcohol EtG Ethyl Glucuronide 3 CLIA WAIVED CLIA (Clinical Laboratory Improvement Amendments) is a lab testing quality standard that was first established in 1988, and became part of the Federal Register in 1992. These standards were developed for both lab based testing and medical devices to ensure a low risk for error. CLIA defines a clinical laboratory as any facility which performs laboratory testing on specimens derived from humans for the purpose of providing information for diagnosis, prevention or treatment of disease or impairment. Some of our products are CLIA Waived and are usually sold within the medical environment like doctor’s offices, Certain Drug & Alcohol treatment centers, pain management clinics and more. 4 25 TESTS PER BOX UNLESS OTHERWISE INDICATED Rev 10-2014 DIP & READ TESTS • Simple Dip and Read Procedure • Adulterant Test Available on Certain Devices • Detects 1-12 Drugs • Results within 5 Minutes • Able to Photocopy Results • Collection Cups Not Included and Sold Separately ONE PANEL DAM-114 AMP DPC-114 PCP DMD-114 MDMA DMO-114 MOP DBA-114 BAR DPP-114 PPX DMA-114 mAMP DTH-114 THC DBZ-114 BZO DOP-114 OPI DMT-114 MTD DTC-114 TCA DCO-114 COC DOX-114 OXY BUP-114 BUP TWO PANEL DOA-124 COC / THC DOA-324 COC / mAMP DOA-424 mAMP / THC THREE PANEL DOA-134 COC / THC / OPI DOA-234 COC / mAMP / THC FOUR PANEL DOA-144 COC / mAMP / THC / OPI DOA-244 COC / AMP / THC / OPI DOA-544 COC / AMP / THC / BZO 5 25 TESTS PER BOX UNLESS OTHERWISE INDICATED Rev 10-2014 DIP & READ TESTS FIVE PANEL DOA-154 COC / AMP / THC / OPI / PCP DOA-254 COC / AMP / mAMP / THC / OPI DOA-354 COC / mAMP / THC / OPI / PCP DOA-454 COC / AMP / mAMP / THC / MOP DOA-1554 COC / mAMP / THC / OPI / MDMA DOA-754 COC / AMP / THC / OPI / BZO DOA-654 COC / mAMP / THC / MOP / BZO FIVE PANEL +ADULTERANTS DUD-154-201 COC / AMP / mAMP / THC / OPI + Adulterants (OX/ SG / pH) +(Nitrite / Glutaraldehyde / Creatinine) SIX PANEL DOA-164 COC / AMP/ mAMP / THC / OPI / PCP DOA-264 COC / AMP / mAMP / THC / OPI / BZO DOA-1264 COC / mAMP / THC / OPI / PCP / MDMA DOA-1364 COC / AMP / mAMP / THC / OPI / MDMA DOA-164-551 COC / AMP / mAMP / THC / OPI / DOX EIGHT PANEL DOA-184 COC / AMP / mAMP / THC / OPI / PCP / BAR / BZO TEN PANEL DOA-1104 COC / AMP / mAMP / THC / MTD / OPI / PCP / BAR / BZO / TCA DOA-1104-531 COC / AMP / MAMP / THC / MTD / MOP / OXY / BAR / BZO / BUP DOA-3104 COC / AMP / mAMP / THC / MTD / OPI / PCP / BAR / BZO / MDMA TEN PANEL +ADULTERANTS DUD-1104-051 COC / THC / OPI / AMP / mAMP / PCP / BZO / BAR / MTD / TCA + Adulterants ( OX / SG / pH / NI / GL / CR ) TWELVE PANEL DOA-1124-011T THC / AMP / BAR / BZO / COC / mAMP / MTD / OPI / OXY / PCP / PPX / MDMA DOA-1124-081 AMP1000 / BAR300 / BZ0300 / BUP10 / COC300 / MAMP1000 / MDMA500 / OPI300 / MTD300 / OXY100 / PCP25 / THC50 6 25 TESTS PER BOX UNLESS OTHERWISE INDICATED Rev 10-2014 DRUGCHECK DIP & READ TESTS • Simple Dip & Read Procedure • Made in the USA • Collection Cups Not Included and Sold Separately • Results in 3 Minutes • Detects 1-12 Drugs • Custom orders available (12 case minimum) 7 25 TESTS PER BOX UNLESS OTHERWISE INDICATED Rev 10-2014 DRUGCHECK DIP & READ TESTS SINGLE PANEL DIP 30110C AMP (1000ng) 30111C OXY (100ng) 30120C MET (1000ng) 30130C COC (300ng) 30140C THC (50ng) THREE PANEL DIP 30311 COC / OPI300 / THC FIVE PANEL DIP 30500 AMP / COC / MET / OPI / THC SIX PANEL DIP 30600 AMP / BZO / COC / MET / OPI / THC EIGHT PANEL DIP 30800 AMP / BZO / COC / MET / MTD / OPI300 / OXY / THC TEN PANEL DIP 31030 AMP / BAR / BZO / COC / MET / MTD / OPI300 / OXY / PCP / THC 31070 AMP / BAR / BUP / BZO / COC / MET / MTD / OPI300 / OXY / THC ELEVEN PANEL DIP 31103 AMP / BAR / BUP / BZO / COC / MET / MTD / OPI300 / OXY / PCP / THC TWELVE PANEL DIP 31205 AMP / BAR / BUP / BZO / COC / MET / MTD / OPI300 / OXY / PCP / PPX / THC 8 25 TESTS PER BOX UNLESS OTHERWISE INDICATED Rev 10-2014 ADDITIONAL DIP & READ Simple Dip and Read Procedure • Detects 1-12 Drugs • Results within 5 Minutes • Able to Photocopy Results • Collection Cups Not Included and Sold Separately FIVE PANEL DIP CARD WDOA-255 AMP / COC / mAMP / MOP / THC WDOA-554 COC / mAMP / MDMA / OPI / THC WDOA-655 BZO / COC / mAMP / MOP / THC SIX PANEL DIP CARD WDOA-564 BZO / COC / mAMP / OPI / OXY / THC WDOA-565 BZO / COC / mAMP / MOP / OXY / THC WDOA-664 AMP / COC / mAMP / OPI / OXY / THC WDOA-865 BUP / BZO / COC / MOP / MTD / OXY 9 25 TESTS PER BOX UNLESS OTHERWISE INDICATED Rev 10-2014 DIP & READ SEVEN PANEL DIP CARD WDOA-274 AMP / BZO / COC / mAMP / OPI / OXY / THC NINE PANEL DIP CARD WDOA-194 AMP / BAR / BZO / COC / mAMP / MTD / OPI / PCP / THC WDOA-295 AMP / BUP / BZO / COC / MOP / MTD / OXY / PPX / THC TEN PANEL DIP CARD WDOA-1105 AMP / BAR / BZO / COC / mAMP / MOP / MTD / PCP / TCA / THC WDOA-2105 AMP / BAR / BZO / COC / mAMP / MOP / MTD / OXY/ TCA / THC WDOA-4104 AMP / BAR / BZO / COC / mAMP / MTD / OPI / OXY / PCP / THC WDOA-4105 AMP / BAR / BZO / COC / mAMP / MOP / MTD / OXY / PCP / THC WDOA-5104 AMP / BAR / BZO / COC / mAMP / MDMA / MTD / OPI / PPX / THC WDOA-7104 BAR / BUP / BZO / COC / mAMP / MTD / OPI / OXY / TCA / THC TWELVE PANEL DIP CARD WDOA-1125 AMP / BAR / BZO / COC / mAMP / MDMA / MOP / MTD / OXY / PCP / PPX / THC WDOA-2125 AMP / BAR / BZO / COC / mAMP / MDMA / MOP / MTD / OXY / PPX / TCA / THC WDOA-3124 AMP / BAR / BUP / BZO / COC / MDMA / MTD / TCA / OPI / OXY / PCP / THC WDOA-6124 AMP / BAR / BUP / BZO / COC / mAMP / MDMA / MTD / OPI / OXY / PCP / THC WDOA-6125 AMP / BAR / BUP / BZO / COC / mAMP / MDMA / MOP / MTD / OXY / PCP / THC 10 25 TESTS PER BOX UNLESS OTHERWISE INDICATED Rev 10-2014 ECONOMY FIVE PANEL DIP & READ This Generic 5-Panel Dip Card drug test is perfect for early analytical drug testing results. The easy to use design allows you to quickly read drug testing results Features: • Accuracy up to 99% • Results within 5 minutes • FDA 510(K) Cleared for professional use FIVE PANEL W254 COC / AMP / mAMP / THC / OPI W654 COC / mAMP / THC / OPI / BZO W754 COC / AMP / THC / OPI / BZO 11 25 TESTS PER BOX UNLESS OTHERWISE INDICATED Rev 10-2014 12 PANEL CLIA WAIVED DIP & READ • Simple Dip and Read Procedure • Results in 5 Minutes • Able to Photocopy Results • Collection Cups Not Included & Sold Separately TWELVE PANEL CLIA WAIVED U-DOA-3124 BZO / BAR / COC / THC / MET / MOP / MTD / TCA / OXY / MDMA / PCP / AMP 12 25 TESTS PER BOX UNLESS OTHERWISE INDICATED Rev 10-2014 SPECIALTY DIP AND READS K2 SPICE URINE Instant Drug Test • Detection time up to 72 hours • 25 ng/ml Cutoff • Results within minutes • K2/Spice test is specific to JWH-018 and JWH-073 • For The Qualitative Assessment Of Synthetic Cannabis (K2) In Human Urine. • Collection cups not included and sold separately U-K2 K2 / Spice SINGLE BUPRENORPHINE CLIA Waived Drug Test The Fastect II Drug Buprenorphine Screen Dipstick Test provides visual qualitative results. The Fastect II Drug Screen Dipstick Test provides only a preliminary screening test result. FEATURES: • Results within 3-5 minutes • FDA 510(K) Cleared for professional use • Collection cups not included and sold separately • PLEASE NOTE: 50 PER BOX MF25 BUP 13 25 TESTS PER BOX UNLESS OTHERWISE INDICATED Rev 10-2014 SPECIALTY DIP AND READS FENTANYL Single Panel • Made in the USA • 10 Ng/ML Cutoff • For Forensic Use Only • Collection cups not included and sold separately 30102C Fentanyl 14 25 TESTS PER BOX UNLESS OTHERWISE INDICATED Rev 10-2014 ADULTERATION ADULTERATION TEST ADULT-7 Creatinine, Nitrite, Glutaraldehyde, Specific Gravity, pH, Oxidants, PPC • 7 Parameter Adulteration Test • 25 Strips Per Jar • Just dip in urine, remove immediately and compare to color chart • Easy to use DUC-111 Creatinine, Nitrite, Glutaraldehyde, Specific Gravity, pH, Oxidants, PPC 15 25 TESTS PER BOX UNLESS OTHERWISE INDICATED Rev 10-2014 NICOTINE TESTS NICOTINE DIP AND READ TEST • Rapid test for the qualitative detection of Cotinine (nicotine metabolite) in human urine • Easy To Use Dip Style • Collection Cups Not Included/Sold Separately U-COT-114 Nicotine NICOTINE PIPETTE TEST • Cotinine (Nicotine) Detection in as Little as 3 Minutes • Accurate and Easy to Use • Collection Pipette Included • Collection Cups Not Included, Sold Separately • PLEASE NOTE: 40 PER BOX DTC-102 Nicotine 16 25 TESTS PER BOX UNLESS OTHERWISE INDICATED Rev 10-2014 ALCO SCREEN ALCO SCREEN • More Sensitive Than a Breathalyzer • Results in 2 Minutes • Provides 4 Ranges of B.A.C.
Load more

Recommended publications
  • Adverse Reactions to Hallucinogenic Drugs. 1Rnstttutton National Test
    DOCUMENT RESUME ED 034 696 SE 007 743 AUTROP Meyer, Roger E. , Fd. TITLE Adverse Reactions to Hallucinogenic Drugs. 1rNSTTTUTTON National Test. of Mental Health (DHEW), Bethesda, Md. PUB DATP Sep 67 NOTE 118p.; Conference held at the National Institute of Mental Health, Chevy Chase, Maryland, September 29, 1967 AVATLABLE FROM Superintendent of Documents, Government Printing Office, Washington, D. C. 20402 ($1.25). FDPS PRICE FDPS Price MFc0.50 HC Not Available from EDRS. DESCPTPTOPS Conference Reports, *Drug Abuse, Health Education, *Lysergic Acid Diethylamide, *Medical Research, *Mental Health IDENTIFIEPS Hallucinogenic Drugs ABSTPACT This reports a conference of psychologists, psychiatrists, geneticists and others concerned with the biological and psychological effects of lysergic acid diethylamide and other hallucinogenic drugs. Clinical data are presented on adverse drug reactions. The difficulty of determining the causes of adverse reactions is discussed, as are different methods of therapy. Data are also presented on the psychological and physiolcgical effects of L.S.D. given as a treatment under controlled medical conditions. Possible genetic effects of L.S.D. and other drugs are discussed on the basis of data from laboratory animals and humans. Also discussed are needs for futher research. The necessity to aviod scare techniques in disseminating information about drugs is emphasized. An aprentlix includes seven background papers reprinted from professional journals, and a bibliography of current articles on the possible genetic effects of drugs. (EB) National Clearinghouse for Mental Health Information VA-w. Alb alb !bAm I.S. MOMS Of NAM MON tMAN IONE Of NMI 105 NUNN NU IN WINES UAWAS RCM NIN 01 NUN N ONMININI 01011110 0.
    [Show full text]
  • Neuroreceptor Activation by Vibration-Assisted Tunneling
    OPEN Neuroreceptor Activation by SUBJECT AREAS: Vibration-Assisted Tunneling BIOPHYSICAL CHEMISTRY Ross D. Hoehn1, David Nichols2, Hartmut Neven3 & Sabre Kais4,5,6 MECHANISM OF ACTION 1Department of Chemistry, Purdue University, West Lafayette, IN 47907, USA, 2Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, USA,3 Google, Venice, CA 90291, USA,4 Department of Received 5 20 October 2014 Chemistry, Purdue University, West Lafayette, IN 47907, USA, Departments of Physics, Purdue University, West Lafayette, IN 47907, USA,6 Qatar Environment and Energy Research Institute, Qatar Foundation, Doha, Qatar. Accepted 20 March 2015 G protein-coupled receptors (GPCRs) constitute a large family of receptor proteins that sense molecular Published signals on the exterior of a cell and activate signal transduction pathways within the cell. Modeling how an 24 April 2015 agonist activates such a receptor is fundamental for an understanding of a wide variety of physiological processes and it is of tremendous value for pharmacology and drug design. Inelastic electron tunneling spectroscopy (IETS) has been proposed as a model for the mechanism by which olfactory GPCRs are activated by a bound agonist. We apply this hyothesis to GPCRs within the mammalian nervous system Correspondence and using quantum chemical modeling. We found that non-endogenous agonists of the serotonin receptor share requests for materials a particular IET spectral aspect both amongst each other and with the serotonin molecule: a peak whose should be addressed to intensity scales with the known agonist potencies. We propose an experiential validation of this model by S.K. (kais@purdue. utilizing lysergic acid dimethylamide (DAM-57), an ergot derivative, and its deuterated isotopologues; we also provide theoretical predictions for comparison to experiment.
    [Show full text]
  • Molecular Mechanisms of Addiction
    Molecular Mechanisms of Addiction Eric J. Nestler Nash Family Professor The Friedman Brain Institute Medical Model of Addiction • Pathophysiology - To identify changes that drugs produce in a vulnerable brain to cause addiction. • Individual Risk - To identify specific genes and non-genetic factors that determine an individual’s risk for (or resistance to) addiction. - About 50% of the risk for addiction is genetic. Only through an improved understanding of the biology of addiction will it be possible to develop better treatments and eventually cures and preventive measures. Scope of Drug Addiction • 25% of the U.S. population has a diagnosis of drug abuse or addiction. • 50% of U.S. high school graduates have tried an illegal drug; use of alcohol and tobacco is more common. • >$400 billion incurred annually in the U.S. by addiction: - Loss of life and productivity - Medical consequences (e.g., AIDS, lung cancer, cirrhosis) - Crime and law enforcement Diverse Chemical Substances Cause Addiction • Opiates (morphine, heroin, oxycontin, vicodin) • Cocaine • Amphetamine and like drugs (methamphetamine, methylphenidate) • MDMA (ecstasy) • PCP (phencyclidine or angel dust; also ketamine) • Marijuana (cannabinoids) • Tobacco (nicotine) • Alcohol (ethanol) • Sedative/hypnotics (barbiturates, benzodiazepines) Chemical Structures of Some Drugs of Abuse Cocaine Morphine Ethanol Nicotine ∆9-tetrahydrocannabinol Drugs of Abuse Use of % of US population as weekly users 100 25 50 75 0 Definition of Drug Addiction • Loss of control over drug use. • Compulsive drug seeking and drug taking despite horrendous adverse consequences. • Increased risk for relapse despite years of abstinence. Definition of Drug Addiction • Tolerance – reduced drug effect after repeated use. • Sensitization – increased drug effect after repeated use.
    [Show full text]
  • Vol. 85 Tuesday, No. 67 April 7, 2020 Pages 19375–19640
    Vol. 85 Tuesday, No. 67 April 7, 2020 Pages 19375–19640 OFFICE OF THE FEDERAL REGISTER VerDate Sep 11 2014 21:02 Apr 06, 2020 Jkt 250001 PO 00000 Frm 00001 Fmt 4710 Sfmt 4710 E:\FR\FM\07APWS.LOC 07APWS khammond on DSKJM1Z7X2PROD with FR-1WS II Federal Register / Vol. 85, No. 67 / Tuesday, April 7, 2020 The FEDERAL REGISTER (ISSN 0097–6326) is published daily, SUBSCRIPTIONS AND COPIES Monday through Friday, except official holidays, by the Office PUBLIC of the Federal Register, National Archives and Records Administration, under the Federal Register Act (44 U.S.C. Ch. 15) Subscriptions: and the regulations of the Administrative Committee of the Federal Paper or fiche 202–512–1800 Register (1 CFR Ch. I). The Superintendent of Documents, U.S. Assistance with public subscriptions 202–512–1806 Government Publishing Office, is the exclusive distributor of the official edition. Periodicals postage is paid at Washington, DC. General online information 202–512–1530; 1–888–293–6498 Single copies/back copies: The FEDERAL REGISTER provides a uniform system for making available to the public regulations and legal notices issued by Paper or fiche 202–512–1800 Federal agencies. These include Presidential proclamations and Assistance with public single copies 1–866–512–1800 Executive Orders, Federal agency documents having general (Toll-Free) applicability and legal effect, documents required to be published FEDERAL AGENCIES by act of Congress, and other Federal agency documents of public Subscriptions: interest. Assistance with Federal agency subscriptions: Documents are on file for public inspection in the Office of the Federal Register the day before they are published, unless the Email [email protected] issuing agency requests earlier filing.
    [Show full text]
  • Novel Hallucinogens and Plant-Derived Highs
    Novel Hallucinogens and Plant-Derived Highs Emily Dye Forensic Chemist Special Testing and Research Laboratory Drug Enforcement Administration Outline • Hallucinogens • Plant-Derived Highs – 2C Compounds – Kratom – NBOMe Compounds – Fly Agaric Mushrooms – DOX Compounds – Kava Kava – Kanna • Empathogens – Aminoindanes – APDB – APB DEA Special Testing and Research Laboratory Emerging Trends Program 2C Compounds • Psychedelic phenethylamines • Synthesized by Alexander Shulgin – Published in PiHKAL • 27 known compounds – Most common: 2C-C, 2C-B, and 2C-I DEA Special Testing and Research Laboratory Emerging Trends Program 2C Compounds DEA Special Testing and Research Laboratory Emerging Trends Program 2C-B-FLY • Psychedelic phenethylamine • Synthesized by Aaron Monte www.erowid.org DEA Special Testing and Research Laboratory Emerging Trends Program Bromo-DragonFLY • Psychedelic phenethylamine • Synthesized in the lab of David Nichols • Deaths associated with misrepresentation as 2C-B-FLY www.erowid.org DEA Special Testing and Research Laboratory Emerging Trends Program NBOMe Compounds • Hallucinogenic phenethylamines • Synthesized by Heim, et al. • Isomers can be distinguished via RT and MS DEA Special Testing and Research Laboratory Emerging Trends Program Name R1 R2 R3 R4 Name R1 R2 R3 R4 25B-NB2OMe Br OCH3 H H 25N-NB2OMe NO2 OCH3 H H 25B-NB3OMe Br H OCH3 H 25N-NB3OMe NO2 H OCH3 H 25B-NB4OMe Br H H OCH3 25N-NB4OMe NO2 H H OCH3 25C-NB2OMe Cl OCH3 H H 25P-NB2OMe CH2CH2CH3 OCH3 H H 25C-NB3OMe Cl H OCH3 H 25P-NB3OMe CH2CH2CH3 H OCH3 H 25C-NB4OMe
    [Show full text]
  • Download Thesisadobe
    Non-targeted analysis of new psychoactive substances using mass spectrometric techniques by Daniel J. Pasin, MRACI A thesis submitted for the Degree of Doctor of Philosophy (Science) University of Technology Sydney 2018 Certificate of authorship and originality I certify that the work in this thesis has not previously been submitted for a degree nor has it been submitted as part of the requirements for a degree except as fully acknowledged within the text. I also certify that the thesis has been written by me. Any help that I have received in my research work and the preparation of the thesis itself has been acknowledged. In addition, I certify that all the information sources and literature used are indicated in the thesis. This research is supported by an Australian Government Research Training Program Scholarship. Production Note: Signature removed prior to publication. Daniel J. Pasin, MRACI 26/02/2018 Acknowledgements Acknowledgements Firstly, I would like to extend my deepest thanks to my primary supervisor, Associate Professor Shanlin Fu. You have been my primary supervisor for both my honours and PhD degrees and over these last 5 years, you have been nothing but supportive, patient and encouraging. I could always rely on you to provide timely feedback and you were always happy to endorse me for post-PhD opportunities. It has been a great pleasure to complete my PhD research under your supervision. I would also like to thank my co-supervisors, Dr. Adam Cawley and Dr. Sergei Bidny. Without your external collaboration, the success of this project could not be possible. Furthermore, I wish to acknowledge the staff at the Australian Racing Forensic Laboratory (ARFL) and Forensic Toxicology Laboratory at NSW FASS for your assistance in this project.
    [Show full text]
  • On Certain Issues of Export and Import Licensing of Goods
    ON CERTAIN ISSUES OF EXPORT AND IMPORT LICENSING OF GOODS The Government of the Republic of Kazakhstan of 12 June 2008, No. 578 _________________________________________________________ Footnote. Title as amended by the Resolution of the Government of the Republic of Kazakhstan of 17 October 2012, No. 1320 (entered into force upon the expiration of twenty-one calendar days after the first official publication). In order to implement the laws of the Republic of Kazakhstan "On State Regulating of Production and Turnover of Ethyl Spirits and Alcohol Products" of 16 July 1999, "On Licensing" of 11 January 2007 and "On Export Control» of 21 July 2007 the Government of the Republic of Kazakhstan HAS DECIDED: Footnote. Preamble, as amended by the Resolution of the Government of the Republic of Kazakhstan from 18 September 2008, No. 861. 1. To approve the attached: 1) excluded by the Resolution of the Government of Kazakhstan of 17 October 2012, No. 1320; 2) The qualification requirements for export and import licensing of goods; 3) The list of goods, export and (or) import subject to licensing; 4) The application form for a license and (or) annexes to a license; 5) forms of licenses and annexes to licenses. Footnote. Paragraph 1, as amended by the Resolution of the Government of the Republic of Kazakhstan 17 October 2012, No.1320. 2. Declare invalid certain Resolutions of the Government of the Republic of Kazakhstan in accordance with the Annex to this Resolution. 3. This Resolution shall come into force upon the expiration of twenty-one calendar days after its official publication. Premier of the Republic of Kazakhstan Karim Massimov Approved by the Resolution of the Government of the Republic of Kazakhstan of 12 June 2008, No.578 The Rules on Export and Import Licensing, Including Licensing of Goods Subject to Export Controls, and Rules on Automatic Import Licensing of Certain Goods Footnote.
    [Show full text]
  • The Role of Norepinephrine in the Pharmacology of 3,4
    !"#$%&'#$&($)&*#+,-#+"*,-#$,-$."#$/"0*102&'&34$&($ 56789#."4'#-#:,&;41#."01+"#.01,-#$<9=9>6$?#[email protected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`,E#-E$ I0--$ D-.#*$ 2*#0.,J#2&11&-@X&*3a',2#-2#@aY48-28 -:aSX]a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
    [Show full text]
  • Chemosensitization of Doxorubicin Against Lung Cancer by Nature Borneol, Involvement of TRPM8- Regulated Calcium Mobilization
    Chemosensitization of doxorubicin against lung cancer by nature borneol, involvement of TRPM8- regulated calcium mobilization Haoqiang Lai Jinan University Chang Liu Jinan University Institute for Economic and Social Research Wenwei Lin Jinan University tf Chen ( [email protected] ) Jinan University An Hong Jinan University Research Keywords: Natural Borneol, DOX, TRPM8, Synergism, Calcium mobilization, Non-small cell lung cancer Posted Date: February 24th, 2020 DOI: https://doi.org/10.21203/rs.2.24354/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/24 Abstract Background Lung cancer possesses high mortality rate and tolerances to multiple chemotherapeutics. Natural Borneol (NB) is a monoterpenoid compound that found to facilitate the bioavailability of drugs. In this study, we attempted to investigate effects of NB on the chemosensitivity in A549 cells and try to elucidate its therapeutic target. Methods The effects of NB on chemosensitivity in A549 cells was examined by MTT assay. The mechanism studies were evaluated by ow cytometry and western blotting assay. Surface plasmon resonance (SPR) and LC-MS combined analysis (MS-SPRi) was performed to elucidate the candidate target of NB contributes to this synergism. The chemosensitizing capacity of NB in vivo was conducted in nude mice bearing A549 tumors. Results NB pretreatment sensitizes A549 cells to low dosage of DOX, leading to a 15.7% to 41.5% increase in apoptosis, which is corelated with ERK and AKT inactivation but activation of phosphor-p38MAPK, -JNK and p53. Furthermore, this synergism depends on reactive oxygen species (ROS) generation. The MS- SPRi analysis reveals that the transient receptor potential melastatin-8 (TRPM8) is the interaction target of NB in potentiating DOX killing potency.
    [Show full text]
  • Doxyl Nitroxide Spin Probes Can Modify Toxicity of Doxorubicin Towards Fibroblast Cells
    molecules Article Doxyl Nitroxide Spin Probes Can Modify Toxicity of Doxorubicin towards Fibroblast Cells Jan Czepas 1,* , Karolina Matczak 2 , Aneta Koceva-Chyła 2 , Bartłomiej Grobelski 1 , Zofia Jó´zwiak 2 and Krzysztof Gwo´zdzi´nski 1 1 Department of Molecular Biophysics, Faculty of Biology and Environmental Protection, University of Łód´z, 141/143 Pomorska st., 90-236 Łód´z,Poland; [email protected] (B.G.); [email protected] (K.G.) 2 Department of Medical Biophysics, Faculty of Biology and Environmental Protection, University of Łód´z, 141/143 Pomorska st., 90-236 Łód´z,Poland; [email protected] (K.M.); [email protected] (A.K.-C.); zofi[email protected] (Z.J.) * Correspondence: [email protected]; Tel.: +48-42-6354452; Fax: +48-42-6354473 Received: 1 October 2020; Accepted: 27 October 2020; Published: 4 November 2020 Abstract: The biological properties of doxyl stearate nitroxides (DSs): 5-DS, Met-12-DS, and 16-DS, commonly used as spin probes, have not been explored in much detail so far. Furthermore, the influence of DSs on the cellular changes induced by the anticancer drug doxorubicin (DOX) has not yet been investigated. Therefore, we examined the cytotoxicity of DSs and their ability to induce cell death and to influence on fluidity and lipid peroxidation (LPO) in the plasma membrane of immortalised B14 fibroblasts, used as a model neoplastic cells, susceptible to DOX-induced changes. The influence of DSs on DOX toxicity was also investigated and compared with that of a natural reference antioxidant α-Tocopherol.
    [Show full text]
  • Synthesis and Cyclic Voltammetry Studies of 3,4-Methylenedioxymethamphetamine (MDMA) Human Metabolites
    Journal of Health Science, 53(1) pp 31–42 (2007) 31 Synthesis and Cyclic Voltammetry Studies of 3,4-Methylenedioxymethamphetamine (MDMA) Human Metabolites Carla Macedo,a Paula Serio´ Branco,∗,a Lu´ısa Maria Ferreira,a Ana Maria Lobo,a Joao˜ Paulo Capela,b Eduarda Fernandes,c Maria de Lourdes Bastos,b and Felix Carvalhob aREQUIMTE/CQFB, Departamento de Qu´ımica, FCT, Universidade Nova de Lisboa, 2829–516 Caparica, Portugal, bREQUIMTE, Departamento de Toxicologia, and cREQUIMTE, Departamento de Qu´ımica-F´ısica, Faculdade de Farm´acia da Universidade do Porto, 4099–1030, Porto, Portugal (Received July 6, 2006; Accepted October 27, 2006) 3,4-Methylenedioxymethamphetamine (MDMA or “Ecstasy”) is a widely abused, psychoactive recreational drug. There are growing evidences that the MDMA neurotoxic profile may be highly dependent on its hepatic metabolism. MDMA metabolism leads to the production ofhighly reactive derivates, namely catechols, cate- chol thioethers, and quinones. In this study the electrochemical oxidation-reduction processes of MDMA human metabolites, obtained by chemical synthesis, were evaluated by cyclic voltammetry based on an electrochem- ical cell with a glassy carbon working electrode. The toxicity of α-methyldopamine (α-MeDA), N-methyl-α- methyldopamine (N-Me-α-MeDA) and 5-(glutathion-S-yl)-α-methyldopamine [5-(GSH)-α-MeDA] to rat cortical neurons was then correlated with their redox potential. The obtained datademonstratedthatthe lower oxidation potential observed for the catecholic thioether of α-MeDA correlatedwith the higher toxicity of this adduct. This accounts for the use of voltammetry data in predicting the toxicity of MDMA metabolites. Key words —— 3,4-Methylenedioxymethamphetamine, Neurotoxicity, Cyclic voltammetry, Metabolites, Rat cortical neurons INTRODUCTION in laboratory animals and humans have been demonstrating that the exposure to MDMA may Theresearch in the area of drug abuse is mainly elicit long-term changes in the neurochemistry and focused in its direct or indirect effects on receptors behavior.
    [Show full text]
  • Day 1 Printable Slides
    Herbal Smoking Blends - SPICE • SPICE and other herbal blends have been sold in head shops and on the Internet since 2006 for their cannabis-like intoxication Classes and Structures of Emerging Cannabimimetics • The herbal blends sometimes have a fragrance and Cathinones which could include vanilla, potpourri, spice, blueberry, caramel, and strawberry Arthur Berrier Senior Research Chemist Special Testing and Research Laboratory • The plant materials for the different blends Drug Enforcement Administration have a wide variation in appearance ~ ) D[A Speco0I Tornnr. oncl lle1ea1ch 1.1boratory ~~ Emt!•t;mg Trends Ptobr,1m Herbal Smoking Blends - SPICE Herbal Smoking Blends - SPICE • In late 2008, THC Pharma reported the • K2 enters market in April, 2009 presence of JWH 018, a synthetic cannabimimetic indole in some blends • Interest booms in herbal smoking blends in 2009 • In early 2009, analogues of CP 47,497 (another synthetic cannabinoid) were also • Many new products appeared, typically with found in some blends by the U. of Freiburg JWH 018 and JWH 073 • In early 2009, several European Countries • States begin to control the blends/synthetic control Herbal Blends/JWH 018/CP 47,497 cannabinoids ~) 0(1\ Spr•c:i.11 f~l'.. [1 ng and Rtl~C!'allh l11hor,1to ry ~ ' ) O(I' S1Jec1a l Tl.?sltng amJ RPWJr< h l .1bor,1tory r"::::> Fme rf;mg Trt>nd. Proc;f.101 ~=> [me1eing Tr!>nth P1ogr.i111 Classes of Synthetic Cannabinoids Herbal Smoking Blends - SPICE Observed on Smoking Blends • Products quickly reformulated with new, non­ i) 2-(3-hydroxycyclohexyl)phenol (CP 47,497) controlled synthetic cannabimimetics ii) 3-(1-naphthoyl)indole (JWH 018) iii) 3-(1-naphthoyl)pyrrole • Five of the synthetic cannabimimetics iv) 1-( 1-naphthylmethylene )indene controlled at the Federal level in 2011 v) 3-phenylacetylindole or 3-benzoylindole • Synthetic Drug Abuse Prevention Act of 2012 ~ ) 11[ •\ "' 1,r( 1,-,1 lf'.',..tr11g and [~p Pnrch lJUOrdto1 y ~ \ DE/\ Special Te1 1ing .1nrJ R·~>P<Hrh I abora\Clly r C :> f 1n~~ 1 ,_,1 r\ , Trc11ds P1L)grJm -r.:---::::>J fniPre1ng lrend'.
    [Show full text]